Filing Details

Accession Number:
0001562180-19-005990
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-10 20:04:39
Reporting Period:
2019-12-09
Accepted Time:
2019-12-10 20:04:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597553 Sage Therapeutics Inc. SAGE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1042021 M Jeffrey Jonas C/O Sage Therapeutics, Inc.
215 First Street
Cambridge MA 02142
President & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-09 7,500 $64.20 54,530 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $63.88 USD to $64.49 USD. The price reported above reflects the weighted average sale price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.